There is an 80% recurrence rate when it comes to ovarian cancer, so the question of ‘what next?’ takes on a huge importance. This is the question that Sarah Gitto, … Continued
In August, OCRA hosted a listening session with the U.S. Food and Drug Administration (FDA) to better understand the impact of Covid-19 on clinical trial participation. Watch the full FDA … Continued
It’s been an incredibly busy end of summer/beginning of fall here at OCRA with a double header of Ovarian Cancer Awareness Month and our Uniting for Hope Ovarian Cancer National Conference. We’ve … Continued
What a whirlwind! You heard a lot from us this September, and we want to take just a moment to tell you how grateful we are for your support throughout … Continued
Some well-known people with deeply personal connections to ovarian cancer have echoed what we’ve been saying all September…this disease is a beast. And it doesn’t get talked about enough. Research … Continued
An important victory for the ovarian cancer community came in 2006 when Congress passed Johanna’s Law. What is Johanna’s Law? Also known as The Gynecologic Cancer Education and Awareness Act, … Continued
In order to understand the complexities of how gene mutations affect an ovarian cancer diagnosis, OCRA-funded researcher Alexander Nikitin, MD, PhD and colleagues looked to see which ones drive, or … Continued
Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative. This unique collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of … Continued
This September, Newk’s Cares, the ovarian cancer awareness movement founded by fast-casual restaurant Newk’s Eatery, will honor the legacy of late co-founder Lori Newcomb with a series of meaningful initiatives online and at all 100+ … Continued
For someone who has spent four decades blazing trails in ovarian cancer research and women’s healthcare, it might seem odd that the one word to sum up Dr. Jonathan Berek’s … Continued
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival.” This was found through a comprehensive … Continued
Find resources and make connections at OCRA’s 2020 National Conference September 29 – October 2, 2020 Early Bird Registration Ends 7/31! We’ll be honest—when we decided to host our annual National … Continued
Get email updates about research news, action alerts, and ways to join the fight.
